Mitochondrial Myopathies
Information
- Disease name
- Mitochondrial Myopathies
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05162768 | Active, not recruiting | Phase 3 | Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) | April 29, 2022 | October 2024 |
| NCT02375438 | Completed | Nutritional Assessment in Mitochondrial Cytopathy | December 2014 | March 2016 | |
| NCT02909400 | Completed | Phase 2 | The KHENERGY Study | September 2016 | July 2017 |
| NCT03432871 | Completed | N/A | Nicotinamide Riboside and Mitochondrial Biogenesis | December 8, 2017 | December 31, 2022 |
| NCT03513835 | Completed | Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies | January 1, 2018 | January 1, 2019 | |
| NCT03728777 | Completed | N/A | Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders | April 9, 2018 | October 1, 2019 |
| NCT03888716 | Completed | Phase 1 | A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease | March 18, 2019 | March 16, 2021 |
| NCT03973203 | Completed | N/A | Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients | June 1, 2014 | December 31, 2018 |
| NCT04165239 | Completed | Phase 2 | The KHENERGYZE Study | October 30, 2019 | May 24, 2022 |
| NCT04538521 | Completed | N/A | NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients | February 11, 2019 | September 18, 2020 |
| NCT05012358 | Completed | Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine | May 1, 2022 | January 22, 2024 | |
| NCT05063721 | Completed | Phase 1 | MABs Therapy m.3243A>G Mutation Carriers | March 1, 2020 | December 1, 2022 |
| NCT02255422 | Completed | Phase 2 | RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR | May 5, 2015 | November 30, 2017 |
| NCT04086329 | Recruiting | Phase 1 | Validation of Oxygen Nanosensor in Mitochondrial Myopathy | January 17, 2023 | November 1, 2024 |
| NCT05199246 | Recruiting | N/A | Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders | December 1, 2021 | July 2024 |
| NCT05199740 | Recruiting | mtDNA Mutation Load Analysis in Mesoangioblasts | December 20, 2022 | July 1, 2026 | |
| NCT05200702 | Recruiting | N/A | Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders | January 5, 2022 | July 2024 |
| NCT05346627 | Recruiting | N/A | Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance. | December 20, 2022 | June 2026 |
| NCT05554835 | Recruiting | Global Registry and Natural History Study for Mitochondrial Disorders | February 1, 2009 | December 2040 | |
| NCT05569122 | Recruiting | Phase 1 | Applying pGz in Mitochondrial Disease | March 22, 2023 | October 2024 |
| NCT05962333 | Recruiting | Phase 2 | Effect and Safety MABs Administration m.3243A>G Mutation Carriers | August 1, 2023 | February 1, 2025 |
| NCT06051448 | Recruiting | Phase 1/Phase 2 | Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). | September 22, 2023 | June 2024 |
| NCT06080568 | Recruiting | Human Mitochondrial Stress-driven Obesity Resistance | October 20, 2023 | December 2025 | |
| NCT06080581 | Recruiting | Mitochondrial Dysfunctions Driving Insulin Resistance | October 20, 2023 | December 2025 | |
| NCT06080594 | Recruiting | N/A | Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance | August 2024 | December 2025 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D017240